Cita APA

Niemann, C. U., Mora-Jensen, H. I., Dadashian, E. L., Krantz, F., Covey, T., Chen, S., . . . Herman, S. E. M. (2017). Combined BTK and PI3Kδ inhibition with acalabrutinib and ACP-319 improves survival and tumor control in CLL mouse model. Clin Cancer Res.

Chicago Style Citation

Niemann, Carsten U., et al. "Combined BTK and PI3Kδ Inhibition With Acalabrutinib and ACP-319 Improves Survival and Tumor Control in CLL Mouse Model." Clin Cancer Res 2017.

Cita MLA

Niemann, Carsten U., et al. "Combined BTK and PI3Kδ Inhibition With Acalabrutinib and ACP-319 Improves Survival and Tumor Control in CLL Mouse Model." Clin Cancer Res 2017.